InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,428.00
(
0.07%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
73.08
(
-1.99%
)
Bitcoin
63,299.18
(
-1.51%
)
Post# of 316942
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cintrix

Send PM Follow Ignore
Followers 363
Posts 113992
Boards Moderated 5
Alias Born 12/28/2000

cintrix

Member Level

Re: None

Tuesday, 03/02/2021 9:32:38 AM

Tuesday, March 02, 2021 9:32:38 AM

Post# of 316942
FGEN down 26% FibroGen Inc. shares declined following the close of trading on Monday after the San Francisco-based pharmaceutical company said that the Food and Drug Administration will hold an advisory-committee meeting to review FibroGen and AstraZeneca's new-drug application for roxadustat.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up